Author:
Bingham Catherine,Fernandez Sandra V.,Fittipaldi Patricia,Dempsey Paul W.,Ruth Karen J.,Cristofanilli Massimo,Katherine Alpaugh R.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Cristofanilli M, Valero V, Buzdar AU, Kau SW, Broglio KR, Gonzalez-Angulo AM, Sneige N, Islam R, Ueno NT, Buchholz TA, Singletary SE, Hortobagyi GN (2007) Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease. Cancer 110(7):1436–1444
2. Alpaugh ML, Tomlinson JS, Kasraeian S, Barsky SH (2002) Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. Oncogene 21(22):3631–3643
3. Molckovsky A, Fitzgerald B, Freedman O, Heisey R, Clemons M (2009) Approach to inflammatory breast cancer. Can Fam Physician 55(1):25–31
4. Cristofanilli M, Buzdar AU, Hortobagyi GN (2003) Update on the management of inflammatory breast cancer. Oncologist 8(2):141–148
5. Dawood S, Cristofanilli M (2011) Inflammatory breast cancer: what progress have we made? Oncology (Williston Park) 25(3):264–273